Bilibili Inc ADR (BILI) concluded trading on Wednesday at a closing price of $20.78, with 4.45 million shares of worth about $92.45 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.32% during that period and on June 25, 2025 the price saw a gain of about 0.39%. Currently the company’s common shares owned by public are about 329.92M shares, out of which, 326.06M shares are available for trading.
Stock saw a price change of 0.87% in past 5 days and over the past one month there was a price change of 9.74%. Year-to-date (YTD), BILI shares are showing a performance of 14.55% which increased to 14.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.72 but also hit the highest price of $31.77 during that period. The average intraday trading volume for Bilibili Inc ADR shares is 4.25 million. The stock is currently trading 5.94% above its 20-day simple moving average (SMA20), while that difference is up 12.39% for SMA50 and it goes to 7.75% higher than SMA200.
Bilibili Inc ADR (NASDAQ: BILI) currently have 329.92M outstanding shares and institutions hold larger chunk of about 21.86% of that.
The stock has a current market capitalization of $6.78B and its 3Y-monthly beta is at 0.88. It has posted earnings per share of -$0.20 in the same period. It has Quick Ratio of 1.36 while making debt-to-equity ratio of 0.35. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BILI, volatility over the week remained 2.64% while standing at 3.11% over the month.
Stock’s fiscal year EPS is expected to rise by 10126.72% while it is estimated to increase by 43.69% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by HSBC Securities on May 21, 2025 offering a Buy rating for the stock and assigned a target price of $22.50 to it. On October 03, 2024, Daiwa Securities Downgrade their recommendations, while on September 26, 2024, Goldman Upgrade their ratings for the stock with a price target of $22.60. Stock get an Equal-weight rating from Morgan Stanley on September 25, 2024.
